327 related articles for article (PubMed ID: 25763014)
1. Live bacterial vaccine vectors: an overview.
da Silva AJ; Zangirolami TC; Novo-Mansur MT; Giordano Rde C; Martins EA
Braz J Microbiol; 2014; 45(4):1117-29. PubMed ID: 25763014
[TBL] [Abstract][Full Text] [Related]
2. Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery.
Lin IY; Van TT; Smooker PM
Vaccines (Basel); 2015 Nov; 3(4):940-72. PubMed ID: 26569321
[TBL] [Abstract][Full Text] [Related]
3. Live bacterial vaccine vector and delivery strategies of heterologous antigen: A review.
Ding C; Ma J; Dong Q; Liu Q
Immunol Lett; 2018 May; 197():70-77. PubMed ID: 29550258
[TBL] [Abstract][Full Text] [Related]
4. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
[TBL] [Abstract][Full Text] [Related]
5. The use of live attenuated bacteria as a delivery system for heterologous antigens.
Garmory HS; Leary SE; Griffin KF; Williamson ED; Brown KA; Titball RW
J Drug Target; 2003; 11(8-10):471-9. PubMed ID: 15203915
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the development of live, attenuated bacterial vectors.
Roland KL; Tinge SA; Killeen KP; Kochi SK
Curr Opin Mol Ther; 2005 Feb; 7(1):62-72. PubMed ID: 15732531
[TBL] [Abstract][Full Text] [Related]
7. Genetic immunization: bacteria as DNA vaccine delivery vehicles.
Becker PD; Noerder M; Guzmán CA
Hum Vaccin; 2008; 4(3):189-202. PubMed ID: 20686358
[TBL] [Abstract][Full Text] [Related]
8. Biological safety concepts of genetically modified live bacterial vaccines.
Frey J
Vaccine; 2007 Jul; 25(30):5598-605. PubMed ID: 17239999
[TBL] [Abstract][Full Text] [Related]
9. Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens.
Stevenson A; Roberts M
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):121-8. PubMed ID: 12832115
[TBL] [Abstract][Full Text] [Related]
10. Attenuated salmonella and Shigella as carriers for DNA vaccines.
Xu F; Ulmer JB
J Drug Target; 2003; 11(8-10):481-8. PubMed ID: 15203916
[TBL] [Abstract][Full Text] [Related]
11. Recombinant vaccine delivery systems and encoded vaccines.
Stover CK
Curr Opin Immunol; 1994 Aug; 6(4):568-71. PubMed ID: 7946044
[TBL] [Abstract][Full Text] [Related]
12. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
Liao J; Gibson JA; Pickering BS; Watnick PI
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
[TBL] [Abstract][Full Text] [Related]
13. Use of attenuated bacteria as delivery vectors for DNA vaccines.
Daudel D; Weidinger G; Spreng S
Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482
[TBL] [Abstract][Full Text] [Related]
14. Mucosal vaccination and therapy with genetically modified lactic acid bacteria.
Wells J
Annu Rev Food Sci Technol; 2011; 2():423-45. PubMed ID: 22129390
[TBL] [Abstract][Full Text] [Related]
15. Plasmid maintenance systems suitable for GMO-based bacterial vaccines.
Spreng S; Viret JF
Vaccine; 2005 Mar; 23(17-18):2060-5. PubMed ID: 15755571
[TBL] [Abstract][Full Text] [Related]
16. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?
Lewis GK
Expert Rev Vaccines; 2007 Jun; 6(3):431-40. PubMed ID: 17542757
[TBL] [Abstract][Full Text] [Related]
17. Stable Recombinant-Gene Expression from a
Vezina B; Allnutt T; Keyburn AL; Wade B; Van TTH; Johanesen P; Lyras D; Moore RJ
Appl Environ Microbiol; 2021 May; 87(11):. PubMed ID: 33741626
[TBL] [Abstract][Full Text] [Related]
18. Bacterial mucosal vaccines: Vibrio cholerae as a live attenuated vaccine/vector paradigm.
Killeen K; Spriggs D; Mekalanos J
Curr Top Microbiol Immunol; 1999; 236():237-54. PubMed ID: 9893363
[No Abstract] [Full Text] [Related]
19. Heterologous Pseudomonas aeruginosa O-antigen delivery using a Salmonella enterica serovar Typhimurium wecA mutant strain.
Bridge DR; Whitmire JM; Makobongo MO; Merrell DS
Int J Med Microbiol; 2016 Nov; 306(7):529-540. PubMed ID: 27476047
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
Loeffler DI; Schoen CU; Goebel W; Pilgrim S
Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
